Ranitidine (ZANTAC).
D000897:Anti-Ulcer Agents; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004381:Duodenal Ulcer / Q000188:drug therapy*; D005663:Furans / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007700:Kinetics; D011899:Ranitidine
D000897:Anti-Ulcer Agents; D005663:Furans; D011899:Ranitidine